EyePoint Pharmaceuticals, Inc. — Director's Dealing 2012

Oct 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2012-10-01

Reporting Person: Hopper Paul (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-10-01	Common Stock	P	5000	$1.62	Acquired	5000	Indirect
2012-10-01	Common Stock	P	5000	$1.61	Acquired	10000	Indirect

Footnotes

F1: The reported purchase was of the Issuer's CHESS Depository Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange under the symbol PVA. Each CDI represents one share of Common Stock.

F2: The Reporting Person and his spouse are the sole stockholders of Kilinwata Investments Pty Limited, a private Australian company of which the Reporting Person's spouse is also a Director. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.